Skip to content

Assess the quality of life of osteosarcoma patients.

Study of quality of life of osteosarcoma patients from a tertiary care cancer center. - BM22

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/01/030177
Enrollment
50
Registered
2021-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

Intervention1: NA: NA Control Intervention1: NA: NA

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Histologically proven, osteosarcoma patients of either gender, whose age is 18 years and above, chemo naive, which have been diagnosed and planned their treatment (curative or palliative) at Tata Memorial Centre. 2) Patients who knows English, Hindi or Marathi language.

Exclusion criteria

Exclusion criteria: 1) Patients refused to give consent. 2) Patient below 18 years of age. 3) Partially treated before. 4) Histologically uncertain diagnosis of osteosarcoma.

Design outcomes

Primary

MeasureTime frame
To study the quality of life of osteosarcoma patients treated with curative intent. To study the quality of life of osteosarcoma patients treated with palliative intent (on palliative chemotherapy or only on best supportive care). Timepoint: 1) Baseline 2) At 3-6 months after chemotherapy (approximately 6-9 months from the decision to treat)

Secondary

MeasureTime frame
1) To study the toxicities associated with chemotherapy for osteosarcoma patients. 2) To see the variables affecting the quality of life in patients with osteosarcoma. Timepoint: 1) Baseline 2) At 3-6 months after chemotherapy (approximately 6-9 months from the decision to treat)

Countries

India

Contacts

Public ContactDr Jyoti Bajpai

Tata Memorial Centre

dr_jyotibajpai@yahoo.co.in022-2417-7287

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026